Till Milde Selected Research

Till Milde Research Topics

Disease

61	Neoplasms (Cancer) 05/2024 - 06/2008
21	Medulloblastoma 01/2024 - 06/2010
9	Glioma (Gliomas) 04/2024 - 11/2013
9	Ependymoma 11/2021 - 03/2009
8	Brain Neoplasms (Brain Tumor) 10/2023 - 07/2013
7	Astrocytoma (Pilocytic Astrocytoma) 10/2023 - 04/2011
7	Neuroblastoma 09/2021 - 10/2008
3	Carcinogenesis 01/2023 - 06/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2012
2	Tuberous Sclerosis (Bourneville's Disease) 12/2023 - 01/2019
2	Inflammation (Inflammations) 01/2023 - 06/2008
2	Genomic Instability 01/2022 - 12/2019
2	Sarcoma (Soft Tissue Sarcoma) 12/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 04/2012 - 03/2009
1	Prostatic Neoplasms (Prostate Cancer) 04/2024
1	Fanconi Anemia (Fanconi's Anemia) 04/2024
1	Rhabdomyoma 12/2023
1	Supraventricular Tachycardia 12/2023
1	Cardiac Arrhythmias (Arrythmia) 12/2023
1	Heart Diseases (Heart Disease) 12/2023
1	Central Nervous System Neoplasms 11/2023
1	Typical Teratoid Rhabdoid Tumor 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Chromothripsis 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Paronychia 09/2020
1	Exanthema (Rash) 09/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Lymphoma (Lymphomas) 12/2019
1	Leukemia 12/2019
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Neutropenia 01/2019
1	Epilepsy (Aura) 01/2019

Drug/Important Bio-Agent (IBA)

15	Histone Deacetylase InhibitorsIBA 01/2024 - 10/2008
11	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 03/2009
7	Mitogen-Activated Protein KinasesIBA 01/2024 - 08/2013
7	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2012
6	ChromatinIBA 01/2023 - 01/2012
6	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 06/2010
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2015
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2010
4	Vorinostat FDA Link 12/2019 - 11/2011
3	entinostat (MS 275)IBA 05/2023 - 06/2020
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2017
3	Dactinomycin (Actinomycin)FDA LinkGeneric 12/2020 - 09/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 07/2013
3	MicroRNAs (MicroRNA)IBA 06/2014 - 04/2012
2	Conditioned Culture MediaIBA 04/2024 - 01/2019
2	Drug CombinationsIBA 01/2024 - 10/2020
2	Everolimus FDA Link 12/2023 - 01/2019
2	trans-sodium crocetinate (crocetin)IBA 12/2023 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2021
2	Histones (Histone)IBA 01/2023 - 01/2012
2	NucleotidesIBA 12/2019 - 01/2016
2	ParaffinIBA 11/2019 - 05/2015
2	Formaldehyde (Formol)FDA Link 11/2019 - 05/2015
2	Messenger RNA (mRNA)IBA 11/2019 - 06/2014
2	Small Interfering RNA (siRNA)IBA 01/2018 - 06/2010
2	nutlin 3IBA 09/2016 - 10/2013
1	CytokinesIBA 04/2024
1	tovorafenibIBA 01/2024
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2023
1	InterferonsIBA 10/2023
1	Adenosine Triphosphate (ATP)IBA 05/2023
1	SenotherapeuticsIBA 01/2023
1	SynaptophysinIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	CateninsIBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	tacedinaline (CI 994)IBA 01/2023
1	ulixertinibIBA 01/2023
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	eprenetapoptIBA 09/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	entrectinibIBA 12/2020
1	trametinibIBA 09/2020
1	NivolumabIBA 06/2020
1	ProteomeIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2019
1	CholesterolIBA 01/2019

Therapy/Procedure

34	Therapeutics 05/2024 - 03/2009
10	Drug Therapy (Chemotherapy) 01/2024 - 11/2011
4	Aftercare (After-Treatment) 12/2023 - 01/2016
4	Precision Medicine 02/2022 - 01/2016
3	Radiotherapy 12/2021 - 12/2012
3	Investigational Therapies (Experimental Therapy) 10/2021 - 01/2016
2	Chemoradiotherapy 01/2020 - 03/2009
2	Transplantation 12/2012 - 11/2011
1	Immunotherapy 01/2023
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2022
1	Maintenance Chemotherapy 12/2021
1	Cranial Irradiation 01/2021
1	Combined Modality Therapy 12/2020
1	Drug Tapering 09/2020